Open Access Open Access  Restricted Access Subscription or Fee Access

Recombinant DNA Technology

Nidhi Aggarwal

Abstract


Recombinant DNA technology was only a dream a century ago, when it was thought that by manipulating the expressions of target genes, desirable qualities could be improved in living beings. Nevertheless, in the recent era, this field has proven distinct impacts in terms of human life progress. Important proteins essential for health concerns and dietary needs can be generated securely, inexpensively, and in adequate quantities thanks to this technology. This technique offers a wide range of uses and has the potential to improve crucial areas of life, such as health, food security, and resistance to a variety of detrimental environmental effects. Furthermore, recombinant medications are now being utilized with confidence, and commercial approvals are being obtained quickly. Bioremediation and the treatment of chronic conditions are additional common uses of recombinant DNA technology, gene therapy, and genetic changes.


Keywords


Recombination, DNA, Technology, Health, Disease

Full Text:

PDF

References


Kumar S., Kumar A. Role of genetic engineering in agriculture. Plant Archives. 2015;15:1–6.

Cardi T, Stewart CN. Progress of targeted genome modification approaches in higher plants. Plant Cell Reports. 2016;35(7):1401–1416..

Lomedico PT. Use of recombinant DNA technology to program eukaryotic cells to synthesize rat proinsulin: a rapid expression assay for cloned genes. Proceedings of the National Academy of Sciences of the United States of America. 1982;79(19):5798–5802.

Ullah MW, Khattak WA, Ul-Islam M, et al. Encapsulated yeast cell-free system: a strategy for cost-effective and sustainable production of bio-ethanol in consecutive batches. Biotechnology and Bioprocess Engineering. 2015;20(3):561–575.

Ullah MW, Khattak WA, Ul-Islam M, et al. Bio-ethanol production through simultaneous saccharification and fermentation using an encapsulated reconstituted cell-free enzyme system. Biochemical Engineering Journal. 2014;91:110–119.

Restifo NP, Dudley ME, Rosenberg SA. Adoptive immunotherapy for cancer: harnessing the T cell response. Nature Reviews Immunology. 2012;12(4):269–281.

Kershaw MH, Westwood JA, Darcy PK. Gene-engineered T cells for cancer therapy. Nature Reviews Cancer. 2013;13(8):525–541.

Danilo M, Eusebio M, Carla PC, et al. In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system. Nature. 2014;516(7531):423–427. doi: 10.1038/nature13902.

Gamuyao R, Chin J. H, Pariasca-Tanaka J, et al. The protein kinase Pstol1 from traditional rice confers tolerance of phosphorus deficiency. Nature. 2012;488(7412):535–539.

Hiruma K, Gerlach N, Sacristán S, et al. Root endophyte Colletotrichum tofieldiae confers plant fitness benefits that are phosphate status dependent. Cell. 2016;165(2):464–474.




DOI: https://doi.org/10.37628/ijger.v8i1.743

Refbacks

  • There are currently no refbacks.